Table 1.
Socio-demographic, clinical, and radiological characteristics of the studied groups
| Severe COVID-19 Group N = 35 |
Moderate COVID-19 Group N = 45 |
Control Group N = 40 |
Test | P-value | |
|---|---|---|---|---|---|
| Age | F 2.13 |
0.12 | |||
| Mean ±SD | 51.37±10.24 | 45.84±11.54 | 48.05±13.56 | ||
| Median (Range) | 53 (37 - 70) | 44 (27 - 69) | 47 (25 - 72) | ||
| Sex | X2 0.61 |
0.74 | |||
| Male | 20 (57.1) | 22 (48.9) | 22 (55.0) | ||
| Female | 15 (42.9) | 23 (51.1) | 18 (45.0) | ||
| Smoking | X2 1.38 |
0.50 | |||
| Yes | 12 (34.3) | 11 (24.4) | 14 (35.0) | ||
| No | 23 (65.7) | 34 (75.6) | 26 (65.0) | ||
| Comorbidity | X2 29.10 |
<0.001 | |||
| Yes | 22 (62.9) | 7 (15.6) | 5 (12.5) | ||
| No | 13 (37.1) | 38 (84.4) | 35 (87.5) | ||
| Comorbidity | X2 34.20 |
<0.001 | |||
| No | 13 (37.1) | 38 (84.4) | 35 (87.5) | ||
| DM | 7 (20.0) | 4 (8.9) | 3 (7.5) | ||
| HTN | 9 (25.7) | 3 (6.7) | 2 (5.0) | ||
| Hepatic | 2 (5.7) | 0 (0.0) | 0 (0.0) | ||
| Renal | 2 (5.7) | 0 (0.0) | 0 (0.0) | ||
| Cardiac | 2 (5.7) | 0 (0.0) | 0 (0.0) | ||
| Fever | 35 (100) | 35 (77.8) | 0 (0.0) | 88.0 | <0.001 |
| Dyspnea | 33 (94.3) | 21 (46.7) | 0 (0.0) | 67.12 | <0.001 |
| Cough | 32 (91.4) | 32 (71.1) | 0 (0.0) | 71.84 | <0.001 |
| Tachycardia | 35 (100) | 0 (0.0) | 0 (0.0) | 120 | <0.001 |
| Wheezy | 13 (37.1) | 6 (13.3) | 0 (0.0) | 19.66 | <0.001 |
| Crepitation | 18 (51.4) | 6 (13.3) | 0 (0.0) | 32.86 | <0.001 |
| CT.CO-RADS | X2 5.901 |
0.052 | |||
| 1 | 0 (0.0) | 0 (0.0) | |||
| 2 | 0 (0.0) | 0 (0.0) | |||
| 3 | 0 (0.0) | 0 (0.0) | |||
| 4 | 9 (25.7) | 8 (17.8) | |||
| 5 | 16 (45.7) | 12 (26.7) | |||
| 6 | 10 (28.6) | 25 (55.6) | |||
| Outcome | X2 8.34 |
<0.001 | |||
| Survived | 29 (82.9) | 45 (100) | |||
| Died | 6 (17.1) | 0 (0.0) |
F = F test of ANOVA, X2 = Chi-square test, SD = Standard deviation, DM; diabetes mellitus, HTN; hypertension, CO-RADS; COVID-19 Reporting and Data System